Biotech Startups
9,920 companies tagged Biotech, with their investors and founders.
HeraSight develops genetic tests for families, including preimplantation embryo screening that uses polygenic risk scores and carrier screening to predict risks for conditions such as Alzheimer's, schizophrenia, cancers, autism, and diabetes. It combines validated polygenic scoring with genetic counseling for prospective parents undergoing IVF.
2 investors
A biotech and AI company that develops tools to reduce the cost of producing animal health medicines. The company serves veterinary and animal health industries.
2 investors
Hermes Biosciences develops a benchtop extracellular vesicle isolation system that purifies exosomes from bodily fluids and cell culture media for research and clinical applications in oncology, degenerative disease, and regenerative medicine.
2 investors
HighLife develops a transcatheter mitral valve replacement (TMVR/TSMVR) technology for patients with moderate to severe mitral regurgitation, implanted in a beating heart while preserving the native valve structure. The medical device company operates across Europe, the USA and Australia, with valves manufactured in Irvine, California.
2 investors
Hijack Bio develops targeted biogenic drug delivery systems with environmental awareness. The company operates in the biotech and pharmaceutical delivery sector.
2 investors
Hinge Bio is a biotechnology company developing next-generation therapeutics based on its GEM-DIMER platform, aimed at improving efficacy and reducing resistance and side effects. Its focus areas include autoimmune and inflammatory diseases, cancer, and other conditions.
2 investors
HLB Panagene develops molecular diagnostics and immunodiagnostics solutions, including cancer biomarkers and respiratory/cardiovascular tests for precision medicine and point-of-care applications. The company serves healthcare systems and diagnostics markets primarily in the Middle East and is expanding into GCC countries and Europe.
2 investors
Holiferm develops and produces performance ingredients using biomanufacturing and fermentation, supplying biosurfactants for use in personal care, cosmetics, and household cleaning products. Its ingredients are used by consumer brands in products such as cleansers, shower foams, surface cleaners, and shampoo bars.
2 investors
Hoofprint Biome develops probiotics and natural enzymes based on microbiome engineering to reduce methane emissions from cattle while improving animal health and feed yield. The company targets livestock and cattle production within sustainable agriculture.
2 investors
HILO is a Hokkaido University spin-out commercializing a drug-efficacy evaluation method based on fluorescence bioimaging technology developed by Professor Yusuke Ohba. The company operates a registered clinical testing laboratory and serves pharmaceutical research and development applications.
2 investors
HutanBio develops marine microalgae-derived biofuels for decarbonizing heavy transport, using industrial-scale production platforms deployed on non-arable land without freshwater consumption. The company's technology is designed to provide low-carbon sustainable fuel alternatives while protecting ecosystems and food systems.
2 investors
2 investors
Hylomorph is a medical device company developing Vesta, a product in the cardiac/implantable device area, working with clinical partners such as Penn Medicine, Sant'Orsola Hospital, and the German Heart Center Charité. The company is headquartered at Technopark Zurich.
2 investors
Addressing unmet needs in gastroenterology and hepatology. (NASDAQ: HPTX) (Acquired Horizon Therapeutics)
2 investors
Biotechnology company developing safe and effective oral formulations of therapies traditionally limited to injections using ionic liquid technology
2 investors
2 investors
IBI-Ag develops selective bio-insecticides based on single domain antibody technology that target specific proteins in insect pests, aimed at helping farmers protect crops with minimal harm to workers, consumers, and the environment. The company operates in the agricultural biotechnology and biological pest control sector.
2 investors
Iconovir is a biotechnology company focused on developing cancer treatments, with a stated mission to cure cancer and restore life to patients.
2 investors
iCorNet develops a tailored cardiac remodeling prevention net using 3D cardiac imaging and computer-controlled knitting technology to treat dilated cardiomyopathy. The device is designed for heart failure patients who do not respond adequately to drug therapy and cannot access cardiac transplantation.
2 investors
2 investors
Ictero develops the CholeSafe System, a minimally invasive gallbladder ablation device for treating gallstone disease. The product targets patients seeking surgical outcomes without associated surgical risks.
2 investors
2 investors
A biotechnology company, founded in 2013, developing regenerative medicine technologies including methods to differentiate stem cells into cardiovascular cells and hydrogel-particle-based layering techniques. Its foundational technologies originate from academic research in Japan.
2 investors
ImageneBio is a clinical-stage biotechnology company developing therapeutics for patients with immunological, autoimmune, and inflammatory diseases. Its focus is on drug candidates with differentiated clinical profiles.
2 investors